1. Home
  2. KN vs DYN Comparison

KN vs DYN Comparison

Compare KN & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knowles Corporation

KN

Knowles Corporation

N/A

Current Price

$31.19

Market Cap

2.8B

ML Signal

N/A

DYN

Dyne Therapeutics Inc.

N/A

Current Price

$15.53

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KN
DYN
Founded
1946
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
KN
DYN
Price
$31.19
$15.53
Analyst Decision
Buy
Strong Buy
Analyst Count
4
17
Target Price
★ $44.00
$34.33
AVG Volume (30 Days)
754.6K
★ 2.2M
Earning Date
10-22-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 118.94
N/A
EPS
★ 0.58
N/A
Revenue
★ $593,200,000.00
N/A
Revenue This Year
$16.10
N/A
Revenue Next Year
$8.85
N/A
P/E Ratio
$57.41
★ N/A
Revenue Growth
★ 7.17
N/A
52 Week Low
$21.35
$14.00
52 Week High
$42.93
$27.31

Technical Indicators

Market Signals
Indicator
KN
DYN
Relative Strength Index (RSI) 39.62 38.49
Support Level $29.41 $14.43
Resistance Level $31.95 $19.48
Average True Range (ATR) 1.45 0.96
MACD 0.03 -0.21
Stochastic Oscillator 17.77 0.56

Price Performance

Historical Comparison
KN
DYN

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: